Z-0355-2027 Class II Ongoing
FDA device recall Z-0355-2027 was initiated by Remel, Inc on Oct 19, 2026 and is designated Class II. Reason for recall: Affected lot did not meet specifications. Product may report false susceptibility to antifungal agents, specifically within the Azole family. The recall status is ongoing. Affected quantity: 33 US, 54 OUS.
Recall details
- Product Type
- Devices
- Report Date
- Nov 11, 2026
- Initiation Date
- Oct 19, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 33 US, 54 OUS
Product description
Yeastone Broth, 11ML, 10/BOX, used in antibiotic susceptibility testing of mycological clinical specimens
Reason for recall
Affected lot did not meet specifications. Product may report false susceptibility to antifungal agents, specifically within the Azole family.
Distribution pattern
Worldwide - US Nationwide distribution in the states of MA and CA. The countries of India, Saudi Arabia, UK.
Code information
YY3462 lot 440400 UDI-DI 848838018817
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0355-2027
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026